Brennan V - Search Results

1

Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost.

Kollmeier MA, Gorovets D, Flynn J, McBride S, Brennan V, Beaudry J, Cohen G, Damato A, Zhang Z, Zelefsky MJ. Kollmeier MA, et al. Among authors: brennan v. Brachytherapy. 2022 Sep-Oct;21(5):599-604. doi: 10.1016/j.brachy.2022.04.006. Epub 2022 Jun 17. Brachytherapy. 2022. PMID: 35725549 Free PMC article.

2

Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer.

Gorovets D, Hopkins M, Kollmeier M, Moore A, Goel A, Shasha D, Brennan V, McBride S, Cohen G, Damato AL, Zelefsky MJ. Gorovets D, et al. Among authors: brennan v. Brachytherapy. 2021 Nov-Dec;20(6):1099-1106. doi: 10.1016/j.brachy.2021.08.006. Epub 2021 Sep 26. Brachytherapy. 2021. PMID: 34588146

3

Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation.

Imber BS, O'Dwyer E, Lobaugh S, McBride SM, Hopkins M, Kollmeier M, Gorovets D, Brennan V, Pike LRG, Gewanter R, Mychalczak B, Zhang Z, Schöder H, Zelefsky MJ. Imber BS, et al. Among authors: brennan v. Urology. 2022 Dec;170:146-153. doi: 10.1016/j.urology.2022.08.035. Epub 2022 Sep 14. Urology. 2022. PMID: 36115426 Free PMC article.

4

SBRT focal dose intensification using an MR-Linac adaptive planning for intermediate-risk prostate cancer: An analysis of the dosimetric impact of intra-fractional organ changes.

Brennan VS, Burleson S, Kostrzewa C, Godoy Scripes P, Subashi E, Zhang Z, Tyagi N, Zelefsky MJ. Brennan VS, et al. Radiother Oncol. 2023 Feb;179:109441. doi: 10.1016/j.radonc.2022.109441. Epub 2022 Dec 19. Radiother Oncol. 2023. PMID: 36549340

5

Validation of the bladder neck as an important organ at risk in prostate seed brachytherapy based on D_2cc: A single-institution, retrospective review.

Wallace ND, Olden KL, Brennan VS, Samuji MM, Jamaluddin MF, McVey G, Dunne MT, Kelly PJ. Wallace ND, et al. J Contemp Brachytherapy. 2023 Apr;15(2):96-102. doi: 10.5114/jcb.2023.126315. Epub 2023 Mar 30. J Contemp Brachytherapy. 2023. PMID: 37215610 Free PMC article.

6

40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body Radiotherapy.

Moore A, Zhang Z, Fei T, Zhang L, Accomando L, Schmitt AM, Higginson DS, Mueller BA, Zinovoy M, Gelblum DY, Yerramilli D, Xu AJ, Brennan VS, Guttmann DM, Grossman CE, Dover LL, Shaverdian N, Pike LRG, Cuaron JJ, Dreyfuss A, Lis E, Barzilai O, Bilsky MH, Yamada Y. Moore A, et al. Among authors: brennan vs. Neurosurgery. 2024 Aug 1;95(2):380-391. doi: 10.1227/neu.0000000000002889. Epub 2024 Mar 8. Neurosurgery. 2024. PMID: 38456696

7

Personalized Treatment Selection Leads to Low Rates of Local Salvage Therapy for Bone Metastases.

Mathis NJ, Doyle CJ, Rosen DB, Wijetunga NA, Vaynrub M, Bartelstein M, Guttmann DM, Brennan VS, Yamada YJ, Gillespie EF, Yerramilli D, Yang JT. Mathis NJ, et al. Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):99-105. doi: 10.1016/j.ijrobp.2021.06.025. Epub 2021 Oct 26. Int J Radiat Oncol Biol Phys. 2022. PMID: 34715255 Free PMC article.

8

A novel dynamic arc treatment planning solution to reduce dose to small bowel in preoperative radiotherapy for rectal cancer.

Brennan VS, Curran B, Skourou C, McVeigh E, Dunne M, O'Sullivan L, O'Neill BDP. Brennan VS, et al. Med Dosim. 2019 Autumn;44(3):258-265. doi: 10.1016/j.meddos.2018.09.005. Epub 2018 Oct 22. Med Dosim. 2019. PMID: 30360940

9

Evaluating the Role of Stereotactic Body Radiation Therapy With Respect to Androgen Receptor Signaling Inhibitors for Oligometastatic Prostate Cancer.

Brennan V, Spektor A, Sweeney C, Choudhury A, Rathkopf D, Pomerantz M, Hertan L, Nguyen P, Martin N, Balboni T, Huynh MA, King M. Brennan V, et al. Adv Radiat Oncol. 2021 Sep 28;7(1):100808. doi: 10.1016/j.adro.2021.100808. eCollection 2022 Jan-Feb. Adv Radiat Oncol. 2021. PMID: 35071831 Free PMC article.

10

Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy (SMART) for Abdominopelvic Oligometastases.

Yang DD, Brennan VS, Huynh E, Williams CL, Han Z, Ampofo N, Vastola ME, Sangal P, Singer L, Mak RH, Leeman JE, Cagney DN, Huynh MA. Yang DD, et al. Int J Radiat Oncol Biol Phys. 2022 Dec 1;114(5):941-949. doi: 10.1016/j.ijrobp.2022.05.016. Epub 2022 May 19. Int J Radiat Oncol Biol Phys. 2022. PMID: 35598799

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters